U.S. FDA rejects Cempra's antibiotic for pneumonia

Dec 29 (Reuters) - Cempra Inc said the U.S. Food

and Drug Administration rejected its antibiotic for

community-acquired bacterial pneumonia (CABP), citing inadequate

data on the drug's impact on the...

Read more